cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Accolade Inc
14 own
16 watching
Current Price
$8.73
$0.11
(1.28%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
0
52-Week High
52-Week High
17.01
52-Week Low
52-Week Low
6.33
Average Volume
Average Volume
0.75M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization0
icon52-Week High17.01
icon52-Week Low6.33
iconAverage Volume0.75M
iconDividend Yield--
iconP/E Ratio--
What does the Accolade Inc do?
Our innovative platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians (including nurses, physician medical directors, and behavioral health specialists). We leverage our integrated capabilities, connectivity with providers and the broader healthcare ecosystem, and longitudinal data to engage across the entire member population, rather than focusing solely on high-cost claimants or those with chronic conditions. We were formed under the laws of the state of Delaware in January 2007 under the name Accretive Care LLC, and we converted to a Delaware corporation under the name Accolade, Inc. in June 2010. Our principal executive offices are located at 1201 Third Avenue, Suite 1700, Seattle, WA 98101, and we have co-headquarters at 660 West Germantown Pike, Suite 500, Plymouth Meeting, PA 19462. Our telephone number is (206) 926-8100. Our website address is www.accolade.com.
Read More
How much money does Accolade Inc make?
News & Events about Accolade Inc.
Zolmax
5 months ago
Accolade (NASDAQ:ACCD Free Report) had its target price lifted by equities research analysts at Wells Fargo Company from $13.00 to $14.00 in a report issued on Friday, The Fly reports. Wells Fargo Companys price objective suggests a potential upside of 3.93% from the ...
Ticker Report
8 months ago
Accolade (NASDAQ:ACCD Get Rating) had its price target increased by Bank of America from $12.50 to $14.50 in a research report report published on Tuesday, The Fly reports. Bank of America currently has a neutral rating on the stock. Several other research analysts have also weighed in on ...
PR Newswire
9 months ago
Accolade Welcomes Lyra Health to Its Trusted Partner Ecosystem Accolade Welcomes Lyra Health to Its Trusted Partner Ecosystem PR Newswire SEATTLE, March 6, 2023 Accolade and Lyra will offer employers purpose-built integrations that help address barriers to behavioral health care SEATTLE, March 6...
Globe Newswire
9 months ago
Co-founder of Concur joins Board after serving as the Companys CIOSEATTLE, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced changes to its Board of Directors. The Company announced today that long-time executive Michael Hilton will step down from his operating role at ...
PR Newswire
10 months ago
Blue Shield of California Launches Virtual Blue Benefit Plan Incorporating Primary, Mental Health, and Specialty Care Blue Shield of California Launches Virtual Blue Benefit Plan Incorporating Primary, Mental Health, and Specialty Care PR Newswire OAKLAND, Calif., Jan. 30, 2023 The nonprofit health...
Frequently Asked Questions
Frequently Asked Questions
What is Accolade Inc share price today?
plus_minus_icon
Can Indians buy Accolade Inc shares?
plus_minus_icon
How can I buy Accolade Inc shares from India?
plus_minus_icon
Can Fractional shares of Accolade Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Accolade Inc stocks?
plus_minus_icon
What is today’s traded volume of Accolade Inc?
plus_minus_icon
What is today’s market capitalisation of Accolade Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Accolade Inc?
plus_minus_icon
What percentage is Accolade Inc down from its 52-Week High?
plus_minus_icon
What percentage is Accolade Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$8.73
$0.11
(1.28%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Establishment Labs Holdings Inc
Establishment Labs Holdings Inc
$25.65
$0.91 (3.68 %)
ModivCare Inc
ModivCare Inc
$37.76
$0.63 (1.70 %)
AbCellera Biologics Inc
AbCellera Biologics Inc
$4.71
$-0.07 (-1.46 %)
Repare Therapeutics Inc
Repare Therapeutics Inc
$5.15
$-0.12 (-2.28 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Establishment Labs Holdings Inc
Establishment Labs Holdings Inc
$25.65
$0.91 (3.68 %)
ModivCare Inc
ModivCare Inc
$37.76
$0.63 (1.70 %)
AbCellera Biologics Inc
AbCellera Biologics Inc
$4.71
$-0.07 (-1.46 %)
Repare Therapeutics Inc
Repare Therapeutics Inc
$5.15
$-0.12 (-2.28 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00